Stockreport

Oramed Initiates Its 90-Day Pivotal Dose-Ranging Clinical Study for Oral Insulin

Oramed Pharmaceuticals Inc.  (ORMP) 
Last oramed pharmaceuticals inc. earnings: 4/6 04:46 pm Check Earnings Report
US:NASDAQ Investor Relations: oramed.com/investors